Pay in 4 interest-free payments of $5.98 Learn more
Ships within 48 hours Β· Estimated delivery Sep 4 - Sep 9
Importantly, tirzepatide carries a boxed warning for thyroid C-cell tumors and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
Monthly medication subscriptions start at $219 per month with introductory pricing ($269 at regular price), with no insurance required
Plus, youll have ongoing support from our healthcare team through regular check-ins to keep you on track
A: Reported adverse effects include dizziness, drowsiness (somnolence), and behavioral changes
The medication is available in 3 mg, 7 mg, and 14 mg tablets, with dosing typically initiated at the lowest strength and titrated upward based on glycemic response and tolerability
&srotate=0)
